Cognitive peptides in research: Semax, Selank, Dihexa and the new generation of peptide nootropics Cognition, the new frontier of research peptide therapy For decades, neuropeptide research focused on the major endocrine axes (hypothalamic-pituitary, opioids, oxytocin)
The FDA usually follows its advisory committees, but it isnt required to
Cortical interneuron fate determination: diverse sources for distinct subtypes
Diabetes in Remission (E11.A) A newer code, E11.A (Type 2 DM without complications, in remission), requires explicit provider documentation using the word remission. This code is appropriate for patients who have achieved sustained euglycemia through significant weight loss (bariatric surgery, intensive lifestyle intervention) and have discontinued all antidiabetic medications
Careful review prevents costly preparation errors during mixing steps